Get started
Author

Nikol Jedlickova

Observed name: Nikol JedliČková
Observed institution: University Hospital Plzen
OpenAlex ID: A5092469560
ENIGMA CHEK2 gether Project: A Comprehensive Study Identifies Functionally Impaired CHEK2 Germline Missense Variants Associated with Increased Breast Cancer Risk
2023 · Lenka Stolarova, Petra Kleiblova, et al. · Clinical Cancer Research · 30
PDF
RAD18 directs DNA double-strand break repair by homologous recombination to post-replicative chromatin
2024 · Matous Palek, Natalie Palkova, et al. · Nucleic Acids Research · 12
Site-saturation functional screens identify PALB2 missense variants associated with increased breast cancer risk
2026 · Rick A.C.M. Boonen, Sabine C. Knaup, et al. · Nature Communications · 1
PDF
Re: ERCC3, a new ovarian cancer susceptibility gene?
2021 · Jana Soukupova, Jana Soukupova, et al. · European Journal of Cancer · 1
Table S3 from ENIGMA CHEK2gether Project: A Comprehensive Study Identifies Functionally Impaired CHEK2 Germline Missense Variants Associated with Increased Breast Cancer Risk
2025 · Lenka Stolarova, Petra Kleiblova, et al.
Table S1 from ENIGMA CHEK2gether Project: A Comprehensive Study Identifies Functionally Impaired CHEK2 Germline Missense Variants Associated with Increased Breast Cancer Risk
2025 · Lenka Stolarova, Petra Kleiblova, et al.
Supplementary Methods 1 from ENIGMA CHEK2gether Project: A Comprehensive Study Identifies Functionally Impaired CHEK2 Germline Missense Variants Associated with Increased Breast Cancer Risk
2025 · Lenka Stolarova, Petra Kleiblova, et al.
Table S2 from ENIGMA CHEK2gether Project: A Comprehensive Study Identifies Functionally Impaired CHEK2 Germline Missense Variants Associated with Increased Breast Cancer Risk
2025 · Lenka Stolarova, Petra Kleiblova, et al.
Figure 3 from ENIGMA CHEK2gether Project: A Comprehensive Study Identifies Functionally Impaired CHEK2 Germline Missense Variants Associated with Increased Breast Cancer Risk
2023 · Lenka Stolarova, Petra Kleiblova, et al.
Figure 3 from ENIGMA CHEK2gether Project: A Comprehensive Study Identifies Functionally Impaired CHEK2 Germline Missense Variants Associated with Increased Breast Cancer Risk
2023 · Lenka Stolarova, Petra Kleiblova, et al.
Figure 5 from ENIGMA CHEK2gether Project: A Comprehensive Study Identifies Functionally Impaired CHEK2 Germline Missense Variants Associated with Increased Breast Cancer Risk
2023 · Lenka Stolarova, Petra Kleiblova, et al.
Figure 5 from ENIGMA CHEK2gether Project: A Comprehensive Study Identifies Functionally Impaired CHEK2 Germline Missense Variants Associated with Increased Breast Cancer Risk
2023 · Lenka Stolarova, Petra Kleiblova, et al.
Figure 6 from ENIGMA CHEK2gether Project: A Comprehensive Study Identifies Functionally Impaired CHEK2 Germline Missense Variants Associated with Increased Breast Cancer Risk
2023 · Lenka Stolarova, Petra Kleiblova, et al.
Table S1 from ENIGMA CHEK2gether Project: A Comprehensive Study Identifies Functionally Impaired CHEK2 Germline Missense Variants Associated with Increased Breast Cancer Risk
2023 · Lenka Stolarova, Petra Kleiblova, et al.
Figure 4 from ENIGMA CHEK2gether Project: A Comprehensive Study Identifies Functionally Impaired CHEK2 Germline Missense Variants Associated with Increased Breast Cancer Risk
2023 · Lenka Stolarova, Petra Kleiblova, et al.
Table S2 from ENIGMA CHEK2gether Project: A Comprehensive Study Identifies Functionally Impaired CHEK2 Germline Missense Variants Associated with Increased Breast Cancer Risk
2023 · Lenka Stolarova, Petra Kleiblova, et al.
Figure 2 from ENIGMA CHEK2gether Project: A Comprehensive Study Identifies Functionally Impaired CHEK2 Germline Missense Variants Associated with Increased Breast Cancer Risk
2023 · Lenka Stolarova, Petra Kleiblova, et al.
Figure 4 from ENIGMA CHEK2gether Project: A Comprehensive Study Identifies Functionally Impaired CHEK2 Germline Missense Variants Associated with Increased Breast Cancer Risk
2023 · Lenka Stolarova, Petra Kleiblova, et al.
Table S2 from ENIGMA CHEK2gether Project: A Comprehensive Study Identifies Functionally Impaired CHEK2 Germline Missense Variants Associated with Increased Breast Cancer Risk
2023 · Lenka Stolarova, Petra Kleiblova, et al.
Figure 1 from ENIGMA CHEK2gether Project: A Comprehensive Study Identifies Functionally Impaired CHEK2 Germline Missense Variants Associated with Increased Breast Cancer Risk
2023 · Lenka Stolarova, Petra Kleiblova, et al.
Figure 1 from ENIGMA CHEK2gether Project: A Comprehensive Study Identifies Functionally Impaired CHEK2 Germline Missense Variants Associated with Increased Breast Cancer Risk
2023 · Lenka Stolarova, Petra Kleiblova, et al.
Figure 6 from ENIGMA CHEK2gether Project: A Comprehensive Study Identifies Functionally Impaired CHEK2 Germline Missense Variants Associated with Increased Breast Cancer Risk
2023 · Lenka Stolarova, Petra Kleiblova, et al.
Table S3 from ENIGMA CHEK2gether Project: A Comprehensive Study Identifies Functionally Impaired CHEK2 Germline Missense Variants Associated with Increased Breast Cancer Risk
2023 · Lenka Stolarova, Petra Kleiblova, et al.
Figure 2 from ENIGMA CHEK2gether Project: A Comprehensive Study Identifies Functionally Impaired CHEK2 Germline Missense Variants Associated with Increased Breast Cancer Risk
2023 · Lenka Stolarova, Petra Kleiblova, et al.
Supplementary Methods 1 from ENIGMA CHEK2gether Project: A Comprehensive Study Identifies Functionally Impaired CHEK2 Germline Missense Variants Associated with Increased Breast Cancer Risk
2023 · Lenka Stolarova, Petra Kleiblova, et al.
Works count: 39
Citation count: 44
H-index: 2
I10-index: 2
Year
Topic
Type